2026.08.13
Leadgene Biomedical Secures Australian TGA Approval for Indoxyl Sulfate Test Kit, Addressing Blind Spots in Kidney Function Assessment—Taiwan's IVD R&D Takes the Global Stage
Leadgene Biomedical’s Indoxyl Sulfate (IS) ELISA Kit has received TGA approval in Australia as a Class 2 IVD medical device. By detecting toxic protein-bound uremic toxins missed by standard tests, this diagnostic tool addresses a major blind spot in kidney disease assessment while highlighting Taiwan’s expanding global presence in precision diagnostics.